Aytu BioPharma, Inc.
Prognozy (mln)
| Okres |
2024-06-30 |
2025-06-30 |
2026-06-30 |
2027-06-30 |
2028-06-30 |
| Przychód (średnia) |
81.33 |
69.15 |
70.54 |
96.49 |
123.35 |
| Przychód Δ r/r |
0.00% |
-14.97% |
2.00% |
36.79% |
27.84% |
| Przychód (min) |
78.60 |
68.39 |
68.17 |
96.17 |
119.20 |
| Przychód (max) |
84.06 |
69.92 |
72.90 |
96.81 |
127.49 |
| EBITDA (średnia) |
-131.27 |
-16.82 |
-17.16 |
-23.47 |
-30.01 |
| EBIT (średnia) |
-146.53 |
-24.74 |
-25.24 |
-34.52 |
-44.13 |
| EBIT % |
-180.17% |
-35.78% |
-35.78% |
-35.78% |
-35.78% |
| Zysk netto (średni) |
-18.00 |
1.86 |
-4.06 |
2.66 |
7.81 |
| Zysk netto % |
-22.13% |
2.70% |
-5.76% |
2.75% |
6.33% |
| EPS (średnia) |
-2.49 |
0.34 |
-0.73 |
0.48 |
1.41 |
| Liczba analityków (Przychody) |
1 |
2 |
2 |
3 |
1 |
| Liczba analityków (EPS) |
1 |
1 |
2 |
1 |
1 |
| symbol |
AYTU |
AYTU |
AYTU |
AYTU |
AYTU |